One hard lesson we should have learned after Wall Street’s collapse and the government’s handling of the bailout is that there is no reason, whatsoever, for us to sacrifice our good faith and trust in former bankers who now run the Treasury and Federal Reserve. And now as the flu season gets ready to kick off amidst much fanfare and predictions of doom due to a new H1N1 influenza virus, there is emerging sufficient information to raise very serious doubts whether our nation’s health authorities are truly serving the public health instead of commercial interests.

If the flu season goes according to schedule, the vaccine industrial complex will be poised to join Wall Street for record year rip-off profits. We will also likely witness huge Pharma executive bonuses and perhaps gold-plated toilets. Even if the CDC statisticians’ crystal ball used to forecast rampant swine flu infections turns into a complete bust—which would only be one more added to many other failed flu predictions back to 1976—it will nevertheless be a very profitable failure as was the economic collapse for the banking cartel. The vaccine industry has now received orders in the range of 3 billion doses during the course of the coming flu season. The World Health Organization would like to vaccinate two thirds (4 billion) of the global community, and the US alone is spending $2 billion to stockpile the nation with upwards to 250 million doses.

In the US, such profits could never be accomplished without a dynamic, marketing initiative to convince Americans that vaccines will keep them protected and alive. And what better public relations machine for the vaccine complex, and all its supporters in health insurance and professional medical institutions, than our very own Centers for Disease Control and the Department of Health and Human Services. Even better, our tax dollars are there to pay for it all. We pay for the comfort in knowing that the CDC’s disinformation campaign will continue to scare us over the major networks and the New York Times. We can also assure vaccine makers that once and for all they are protected from liability in the event of serious flu vaccine injuries.